Allworth Financial’s Kazia Therapeutics KZIA Stock Holding History

Allworth Financial’s Portfolio KZIA Stock Details KZIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15	Hold	1	–	–	﹤0.01%	5115
2026 Q1	$8	Hold	1	–	–	﹤0.01%	5158
2025 Q4	$7	Hold	1	–	–	﹤0.01%	4971
2025 Q3	$8	Hold	1	–	–	﹤0.01%	4878
2025 Q2	$7	Buy	+1	New	+$5	﹤0.01%	4561
2025 Q1	–	Sell	-2	Closed	-$12	–	4039
2024 Q4	$11	Hold	2	–	–	﹤0.01%	3909
2024 Q3	$38	Hold	2	–	–	﹤0.01%	3698
2024 Q2	$46	Hold	2	–	–	﹤0.01%	3628
2024 Q1	$27	Hold	2	–	–	﹤0.01%	3551
2023 Q4	$39	Hold	2	–	–	﹤0.01%	3382
2023 Q3	$87	Hold	2	–	–	﹤0.01%	3352
2023 Q2	$101	Hold	2	–	–	﹤0.01%	3172
2023 Q1	$90	Buy	+2	New	+$96	﹤0.01%	3104

Other funds holding KZIA

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

FLPIM

F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

DIG

Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Allworth Financial's KZIA Position: Q2 2026 in Review

Allworth Financial held its Kazia Therapeutics (KZIA) position steady in Q2 2026 at 1 share worth $15. The position accounts for ﹤0.01% of the portfolio, ranked #5115.

Allworth Financial first reported a position in KZIA in Q1 2023 and has held it in 13 quarters since. The position peaked at $101 in Q2 2023. 35 funds tracked by Wall St. Rank hold KZIA as of Q2 2026.

Allworth Financial held 1 share of Kazia Therapeutics worth $15 as of Q2 2026.
Allworth Financial left its Kazia Therapeutics share count unchanged in Q2 2026.
Kazia Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #5115 holding.
Allworth Financial first reported a position in Kazia Therapeutics in Q1 2023 and has held it in 13 quarters since.
Allworth Financial's Kazia Therapeutics position peaked at $101 in Q2 2023.
35 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.